Background: Cervical cancer is the fourth most common cancer among women across the world. Recent studies have shown that cervical cancer is not only caused by persistent infection of human papillomavirus (HPV), but sexually transmitted infections (STIs) also play a role in the pathogenesis of abnormal cervical cells. STIs frequently occur with no specific symptoms, such as the infections caused by Chlamydia trachomatis and Mycoplasma hominis. Asymptomatic STIs could lead to persistent infection. Persistent infections caused by STIs have been hypothesised to increase the access of HPV into the deeper cervical tissue and cause cervical cell abnormalities. Therefore, we conducted this study to assess the association between C. trachomatis and M. hominis infections and abnormal cervical cells. Methods: A cross-sectional study was performed on 58 outpatients at the Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Abnormal cervical cells were detected by a liquidbased cytology Pap smear, and bacterial identification was done by conducting conventional duplex polymerase chain reaction (PCR). Results: 58 patients, 14 (24.1%) showed abnormal cervical cells, whereas 44 (75.9%) patients showed normal cervical cells. The conventional duplex PCR demonstrated a positive result for C. trachomatis and M. hominis bacterial infections in only 1 (7.1%) and 2 (14.3%) patients with abnormal cervical cells, respectively. The statistical analysis revealed no significant association between the bacterial infections and the abnormal cervical cytology in the patients (p > 0.05). Conclusions: Infections caused by C. trachomatis and/or M. hominis were not associated with abnormal cervical cells.
Introduction
Cervical cancer is the fourth most common malignancy among women across the world, and it is the second leading cause of female cancer in Indonesia. 1 Reports on human papillomavirus (HPV) and related diseases from Indonesia have shown that the incidence of cervical cancer is 20.928 cases/year with 9.498 deaths/year. 1 These data indicate that the morbidity and the mortality of cervical cancer are high, wherein the mortality rate is about 50% of the morbidity rate each year. Persistent infections caused by HPV have been reported to be the primary aetiology of pre-cancerous lesions and cervical cancer. 2, 3 HPV was detected in 90% of cervical cancer cases, with the majority being HPV-16 and -18 types. 2, 3 Cervical cancer, which is initiated by precancerous lesions, can be detected using a liquid-based cytology (LBC) Pap smear. 4 These pre-cancerous lesions are caused by persistent HPV infections, and they are also involved in other risk factors, such as other sexually transmitted infections (STIs). 5, 6 STIs have been hypothesised as risk factors for pre-cancerous cervical lesions, because these infections could cause persistent infections with no specific symptoms. These persistent infections can increase the access of HPV into the deeper cervical tissue. 5, 6 54 Among STIs, several studies have reported that infections caused by C. trachomatis and M. hominis play an important role in the persistence of HPV infection, leading to cervical cancer. [5] [6] [7] C. trachomatis infection could inhibit the apoptosis of infected cells, 5, 8 whereas M. hominis infection could suppress the cell-mediated immunity. 9, 10 These mechanisms render the infected cervical cells to become more susceptible to HPV infection and lead to HPV persistence. 9 A study in Korea reported that C. trachomatis infections were significantly higher in abnormal cervical cells than in normal cells. 6 Another study from Argentina demonstrated that C. trachomatis infections were higher in HPV-positive (34.2%) than in HPV-negative subjects (19%). 5 M. hominis was detected in 5.33% of abnormal cervical cells. 9 Yet another study from Nigeria showed a significant association between M. hominis and persistent HPV. 10 To our knowledge, there is no report about the roles of C. trachomatis and M. hominis infections as risk factors for abnormal cervical cells in patients from Indonesia. Therefore, we conducted this cross-sectional study to determine the association between C. trachomatis and M. hominis infections and abnormal cervical cells.
Methods
Study Population. A total of 58 female outpatients attending the Colposcopy Outpatient Clinic, Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital (RSCM), Jakarta, Indonesia, during June to October 2016, were included in this cross-sectional study. The participants were aged 20-67 years and were sexually active. Patients who were pregnant and received antibiotics during the past 4 weeks were excluded. This study was approved by the Ethics Committee of the Faculty of Medicine, Universitas Indonesia, with no: 98/UN2.F1/ETIK/2016, and all subjects provided the written informed consent for participation in the study.
Specimens. Samples of cervical swabs collected by specialist doctors were immediately inserted into LBC vials (LiquiPrep, LGM International Inc, USA). The samples were aliquoted into two tubes, each 5 mL, for LBC Pap smear and polymerase chain reaction (PCR). Transportation and storage of the samples were maintained at 4 °C, and the samples were processed within not more than 2 days from the day of collection.
LBC Pap Smear. LBC Pap smears were performed according to the manufacturer's protocol (LiquiPrep,
LGM International Inc, USA) under the supervision of a pathologist. Normal and abnormal cells were classified according to the Bethesda classification system as follows: negative for intra-epithelial lesions or malignancy (NILM), atypical squamous cells of undetermined significance (ASCUS), atypical squamous cells-cannot exclude HSIL (ASCH), low-grade squamous intra-epithelial lesion (LSIL) and high-grade squamous intra-epithelial lesion (HSIL). 11 The ASCUS, ASCH, LSIL and HSIL were classified as results depicting an abnormal cervical cytology.
DNA Extraction. One millilitre of samples was centrifuged at 13,000 rpm for 30 min. The pellet was suspended in 200 µL of phosphate-buffered saline (PBS) and extracted in accordance with the manufacturer's protocol (High Pure PCR Template Preparation Kit, Roche, Germany) using 50 µL of the final elute. Sample collection and DNA extraction were validated by PCR conducted using standard β-globin primers (Figure 1 ). 
Results
In total, 58 patients who participated in this study, 44 (75.9%) and 14 (24.1%) patients were diagnosed with normal (NILM) and abnormal cervical cytology results, respectively. Of the 14 patients with an abnormal cervical cytology, 6 (12.5%) had ASCUS, 4 (8.3%) had ASCH, 1 (2.1%) had LSIL and 3 (6.3%) patients had HSIL. 
Discussion
HPV, especially the high-risk genotypes, is known as an aetiological agent causing cervical cancer disease. However, the changes from normal to cancerous cervical cells are influenced by several risk factors. 2, 5, 6 One of the risk factors is sexually transmitted bacterial infections, including the infections causing by C. trachomatis and M. hominis. 5, 6 The specific role of bacterial infections in regulating the changes in cervical cells of HPV-infected women has not yet been delineated. A possible explanation is that the bacterial infections may increase the susceptibility of women to HPV infection through changes in cervical cells leading to a higher susceptibility to HPV infection. 5, 14 Several studies have demonstrated the association between bacterial infections and the development of abnormal cervical cells. 5, 6, 14, 15 C. trachomatis has been reported to be the topmost aetiological agent causing STIs across the world, with approximately 89 million cases/year. 5 This bacterial infection has also been reported to play an important role in the development of abnormal cervical cells. These infections might lead to chronic and persistent infections and inflammation, leading to the inhibition of cell apoptosis and metaplasia in cervical squamous cells, thereby rendering the cells susceptible to HPV infection. 5, 16 Moreover, the persistent infection might lead the persistence of HPV, which is an indicator for the development of cervical cancer. 17 In Indonesia, the prevalence of C. trachomatis infection has been reported to be about 7.9%. 18 However, there is no information regarding the association between C. trachomatis infection and abnormal cervical cells. In the present study, we found no significant association between C. trachomatis and abnormal cervical cytology, with the p value being 0.241. This result was consistent with that reported by de Castro-Sobrinho et al., 19 with the p value being 0.2 in their study. In contrast, another study reported that abnormal cervical cells showed a higher percentage of positive C. trachomatis. 6 This difference in results might be caused due to several factors, in particular, the local customs, the behaviour and the risk exposure of particular women. 20 Besides C. trachomatis, we also investigated the role of M. hominis as a risk factor for the development of abnormal cervical cells. The bacterium can be found as a commensal agent in healthy women, but it can be a harmful agent in sexually active women. 9, 21 Several studies have demonstrated the association between M. hominis infection and cervical problems. [21] [22] [23] Indeed, a study reported that M. hominis infection could suppress the cell-mediated immunity, an important protective mechanism against HPV infection. 9,10 However, in this study, we found no such association between M. hominis infection and abnormal cervical cells (p = 0.348). Although there was no statistically significant association, the percentage of M. hominis in patients with an abnormal cervical cytology was higher (14.3%) than that in patients with a normal cervical cytology (7%). Similarly, other studies conducted by Farag et al., 9 Choi et al. 6 and Kim et al. 24 also showed no significant association between M. hominis and abnormal cervical cytology.
A limitation of this study is that we did not analyse the association between C. trachomatis and/or M. hominis and infections caused by HPV, an aetiological virus causing cervical cancer disease. In addition to these bacterial infections, it is necessary to include STIs caused by other bacteria such as Ureaplasma urealyticum and U. parvum in future studies.
Moreover, further research using a larger population must be conducted. The status of other STI-causing agents and HPV infection may be used as a research variable. The findings of this study may be used as information to improve the quality of treatment of patients with pre-cancerous cervical lesions, by including the microbiological examination of women with an abnormal cervical cytology.
Conclusions
This study demonstrated that C. trachomatis and/or M. hominis infections have no significant association with an abnormal cervical cytology. However, it is known that HPV infections alone do not influence the changes from normal to abnormal cervical cells. There are several risk factors influencing the cellular changes, one of them being sexually transmitted bacterial infections. Therefore, it is necessary to address other sexually transmitted bacterial infections besides C. trachomatis and M. hominis in future studies.
